<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>NYS:ABBV on 无关紧要的宇宙</title><link>https://316140221.github.io/Hugo/zh/tags/nysabbv/</link><description>Recent content in NYS:ABBV on 无关紧要的宇宙</description><generator>Hugo</generator><language>zh-CN</language><lastBuildDate>Wed, 30 Jul 2025 22:02:25 +0800</lastBuildDate><atom:link href="https://316140221.github.io/Hugo/zh/tags/nysabbv/index.xml" rel="self" type="application/rss+xml"/><item><title>AbbVie in Talks to Acquire Gilgamesh in $1 Billion Deal</title><link>https://316140221.github.io/Hugo/zh/en/finance/2025-07-30-abbvie-in-talks-to-acquire-gilgamesh-in-1-billion-/</link><pubDate>Wed, 30 Jul 2025 22:02:25 +0800</pubDate><guid>https://316140221.github.io/Hugo/zh/en/finance/2025-07-30-abbvie-in-talks-to-acquire-gilgamesh-in-1-billion-/</guid><description>AbbVie Inc. is in talks to acquire mental health therapeutics company Gilgamesh Pharmaceuticals in a deal highlighting growing takeover interest in the sector, according to people familiar with the ma</description></item><item><title>AbbVie in Talks to Acquire Gilgamesh in $1 Billion Deal</title><link>https://316140221.github.io/Hugo/zh/zh/finance/2025-07-30-abbvie-in-talks-to-acquire-gilgamesh-in-1-billion-/</link><pubDate>Wed, 30 Jul 2025 22:02:25 +0800</pubDate><guid>https://316140221.github.io/Hugo/zh/zh/finance/2025-07-30-abbvie-in-talks-to-acquire-gilgamesh-in-1-billion-/</guid><description>AbbVie Inc. is in talks to acquire mental health therapeutics company Gilgamesh Pharmaceuticals in a deal highlighting growing takeover interest in the sector, according to people familiar with the ma</description></item><item><title>Glenmark-AbbVie Deal Lifts Optimism on India’s Biotech Stocks</title><link>https://316140221.github.io/Hugo/zh/en/finance/2025-07-11-glenmark-abbvie-deal-lifts-optimism-on-indias-biot/</link><pubDate>Fri, 11 Jul 2025 08:43:26 +0800</pubDate><guid>https://316140221.github.io/Hugo/zh/en/finance/2025-07-11-glenmark-abbvie-deal-lifts-optimism-on-indias-biot/</guid><description>Glenmark Pharmaceuticals Ltd.’s licensing pact with AbbVie Inc. for its blood cancer drug is boosting optimism over Indian biotechnology stocks, with some brokerages calling it the largest such deal i</description></item><item><title>Glenmark-AbbVie Deal Lifts Optimism on India’s Biotech Stocks</title><link>https://316140221.github.io/Hugo/zh/zh/finance/2025-07-11-glenmark-abbvie-deal-lifts-optimism-on-indias-biot/</link><pubDate>Fri, 11 Jul 2025 08:43:26 +0800</pubDate><guid>https://316140221.github.io/Hugo/zh/zh/finance/2025-07-11-glenmark-abbvie-deal-lifts-optimism-on-indias-biot/</guid><description>Glenmark Pharmaceuticals Ltd.’s licensing pact with AbbVie Inc. for its blood cancer drug is boosting optimism over Indian biotechnology stocks, with some brokerages calling it the largest such deal i</description></item></channel></rss>